Merrifield C Ann (CIK 0001247224)

Latest company ownership

Shares held
30,000
Last filed at
Jun 14, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 10, 2022 Jun 13, 2022 Lyra Therapeutics, Inc. Director Buy 91.3 +4,000 54.59% $20.2K
May 13, 2022 May 17, 2022 Lyra Therapeutics, Inc. Director Buy 91.3 +3,828 109.37% $18.5K
Jun 17, 2021 Jun 22, 2021 Lyra Therapeutics, Inc. Director Buy 91.3 +3,500 100.00% $31.4K